Tickling the brain with low-intensity electrical stimulation in a specific area can improve verbal short-term memory. Mayo Clinic researchers report their findings in Brain. The researchers found word recall was enhanced with stimulation of the brain’s lateral temporal cortex, the regions on the sides of the head by the temples and ears. Patients recalled more words from a previously viewed list when low-amplitude electrical stimu...

Stroke is the leading cause of permanent disability in the U.S., striking nearly 800,000 people each year. Hemorrhagic, or bleeding, stroke is particularly devastating, says Mayo Clinic neurologist and critical care expert Dr. William D. Freeman. "About 40% of hemorrhagic stroke patients die within a month, and half of the survivors have some type of impairment," he adds.

Early-stage breast cancer patients now have a fast-track treatment option at Mayo Clinic. Select, low-risk patients are completing their surgery and radiation in less than 10 days. "It’s a great option for women who are really, really busy and would like to complete all their therapy within a [short] time frame and get on with the rest of their life," says Dr. Tina Hieken, a Mayo Clinic surgeon who helped develop the program.

  Mayo Clinic researchers used electrical stimulation on the spinal cord and intense physical therapy to help a man intentionally move his paralysed legs, stand and make steplike motions for the first time in three years. The case, the result of collaboration with UCLA researchers, appears in Mayo Clinic Proceedings.

Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool. Their work appears in the EMBO Journal. The team led by Haojie Huang, Ph.D., a Mayo Clinic tumor biologist within Mayo Clinic's Center for Biomedical Discovery identified the role of FOXO1 in chemotherapy resistance. They also identified a potential therapeutic tool by engineering a peptide, which is a sh...

Mayo Clinic and vMocion, LLC, an entertainment technology company, announced it is making available Mayo Clinic's patented Galvanic Vestibular Stimulation (GVS) technology specifically for use in VR and AR. vMocion's 3v Platform (which stands for virtual, vestibular and visual) incorporates this patented GVS technology, which adds a complete sense of 3D movement for the first time into a VR or AR environment.

A team of researchers with the Mayo Clinic has learned more about how a transcription factor known as FOXA1 forms cancer-specific genomic identifiers and how it regulates gene expression differently among four very different types of human cancer cell lines. In their paper published in the journal Science Advances, the team describes how they used gene editing techniques and other tools to learn more about the unique binding process that allows t...